Article info
PDFCommentary
Defending genetic disenhancement in xenotransplantation
- Correspondence to Mr Daniel Rodger, Allied Health Sciences, London South Bank University School of Health and Social Care, London, UK; daniel.rodger{at}lsbu.ac.uk
Citation
Defending genetic disenhancement in xenotransplantation
Publication history
- Received August 7, 2024
- Accepted August 8, 2024
- First published August 21, 2024.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Attitudes of Swedes to marginal donors and xenotransplantation
- The promise of xenotransplantation: a challenge
- Genetic disenhancement and xenotransplantation: diminishing pigs’ capacity to experience suffering through genetic engineering
- Starting clinical trials of xenotransplantation—reflections on the ethics of the early phase
- A “Queen of Hearts” trial of organ markets: why Scheper-Hughes’s objections to markets in human organs fail
- Ethics, organ donation and tax: a proposal
- 3D bioprint me: a socioethical view of bioprinting human organs and tissues
- How should doctors approach patients? A Confucian reflection on personhood
- Fidelity to the healing relationship: a medical student's challenge to contemporary bioethics and prescription for medical practice
- “One man’s trash is another man’s treasure”: exploring economic and moral subtexts of the “organ shortage” problem in public views on organ donation